LLY

1,004

-0.33%↓

JNJ

226.76

-1.74%↓

ABBV

210.42

-0.19%↓

UNH

393.66

-1.34%↓

AZN

181.62

-1.79%↓

LLY

1,004

-0.33%↓

JNJ

226.76

-1.74%↓

ABBV

210.42

-0.19%↓

UNH

393.66

-1.34%↓

AZN

181.62

-1.79%↓

LLY

1,004

-0.33%↓

JNJ

226.76

-1.74%↓

ABBV

210.42

-0.19%↓

UNH

393.66

-1.34%↓

AZN

181.62

-1.79%↓

LLY

1,004

-0.33%↓

JNJ

226.76

-1.74%↓

ABBV

210.42

-0.19%↓

UNH

393.66

-1.34%↓

AZN

181.62

-1.79%↓

LLY

1,004

-0.33%↓

JNJ

226.76

-1.74%↓

ABBV

210.42

-0.19%↓

UNH

393.66

-1.34%↓

AZN

181.62

-1.79%↓

Inicio・Lista de Acciones・Stryker Corp

Stryker Corp

Cerrado

SectorSanidad

306.35 0.28

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

303.12

Máximo

310.87

Métricas clave
By Trading Economics
Ingresos	-104M 745M
Ventas	-1.2B 6B
P/B Media del Sector	32.668 51.415
BPA	1.93
Rentabilidad por dividendo	1.21
Margen de beneficios	12.375
Empleados	56,000
EBITDA	-478M 1.2B

Recomendaciones
By TipRanks
Recomendaciones	Compra Fuerte
Estimación a 12 Meses	+29.65% upside

Dividendos
By Dow Jones
Rentabilidad por dividendo Media del Sector	1.21% 2.34%
Próximas Ganancias	30 jul 2026
Fecha Próximo Dividendo	30 jul 2026
Próxima Fecha de Ex Dividendo	29 jun 2026

Estadísticas de Mercado
By TradingEconomics
Capitalización Mercado	-18B 108B
Apertura anterior	306.07
Cierre anterior	306.35

Noticias sobre sentimiento de mercado

By Acuity

35%

65%

108 / 345 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Weak Bullish Evidence

373.92 / 383.99 Soporte y Resistencia

Stryker Corp Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

30 abr 2026, 20:41 UTC

Ganancias

Stryker 1Q Sales, Profit Rise as it Dealt with Cyberattack

12 mar 2026, 21:42 UTC

Noticias de Eventos Importantes

Stryker Says Cyberattack Disruption Is Continuing

11 mar 2026, 19:18 UTC

Principales Movimientos del Mercado

Stryker Shares Down After Cyberattack Tied to Iran-Linked Group

29 ene 2026, 22:05 UTC

Ganancias

Stryker Logs Higher 4Q Profit On Sales Gains

30 oct 2025, 20:36 UTC

Ganancias

Stryker Lifts Fiscal Year Sales View After 3Q Revenue Rises

30 abr 2026, 20:06 UTC

Ganancias

Stryker 1Q Organic Net Sales Up 2.4%

30 abr 2026, 20:06 UTC

Ganancias

Stryker Backs FY26 Adj EPS $14.90-Adj EPS $15.10 >SYK

30 abr 2026, 20:05 UTC

Ganancias

Stryker Still Sees FY26 Organic Sales Grwoth 8% to 9.5%

30 abr 2026, 20:05 UTC

Ganancias

Stryker 1Q Adj EPS $2.60 >SYK

30 abr 2026, 20:05 UTC

Ganancias

Stryker 1Q EPS $1.93 >SYK

30 abr 2026, 20:05 UTC

Ganancias

Stryker 1Q Net $745M >SYK

30 abr 2026, 20:05 UTC

Ganancias

Stryker 1Q Sales $6.02B >SYK

30 abr 2026, 20:05 UTC

Ganancias

Stryker 1Q Net $745M >SYK

30 abr 2026, 20:05 UTC

Ganancias

Stryker 1Q Adj EPS $2.60 >SYK

30 abr 2026, 20:05 UTC

Ganancias

Stryker 1Q EPS $1.93 >SYK

30 abr 2026, 20:05 UTC

Ganancias

Stryker 1Q Sales $6B >SYK

9 abr 2026, 20:55 UTC

Ganancias

Stryker: Believes Incident Hasn't Had, and Isn't Reasonably Likely to Have, a Material Impact on 2026 Full-Year Guidance >SYK

9 abr 2026, 20:55 UTC

Ganancias

Stryker: Determined Incident Had Material Impact on Operations, With Resulting Impact on Financial Results for 1Q >SYK

9 abr 2026, 20:55 UTC

Ganancias

Stryker: Investigation of Cybersecurity Incident Remains Ongoing >SYK

16 mar 2026, 00:00 UTC

Noticias de Eventos Importantes

Hack on U.S. Medical Company Shows Reach of Iran's Cyber Capabilities -- WSJ

30 ene 2026, 17:03 UTC

Charlas de Mercado

Stryker's 4Q Results Signal 2026 Growth -- Market Talk

29 ene 2026, 21:07 UTC

Ganancias

Stryker Sees 2026 Organic Net Sales Growth 8%-9.5%

29 ene 2026, 21:05 UTC

Ganancias

Stryker 4Q Adj EPS $4.47 >SYK

5 nov 2025, 19:38 UTC

Ganancias

This Healthcare Stock Is the Worst Performer in the S&P 500 Today. Here's Why. -- Barrons.com

5 nov 2025, 17:00 UTC

Ganancias

This Healthcare Stock Is Worst Performer in the S&P 500 Today. Here's Why. -- Barrons.com

30 oct 2025, 20:21 UTC

Ganancias

Stryker Lifts FY Sales View After 3Q Revenue Rises

30 oct 2025, 20:05 UTC

Ganancias

Stryker 3Q Adj EPS $3.19 >SYK

30 oct 2025, 20:05 UTC

Ganancias

Stryker 3Q EPS $2.22 >SYK

30 oct 2025, 20:05 UTC

Ganancias

Stryker 3Q Sales $6.1B >SYK

30 oct 2025, 20:05 UTC

Ganancias

Stryker 3Q Net $859M >SYK

Comparación entre iguales

Cambio de precio

Stryker Corp previsión

Precio Objetivo

By TipRanks

29.65% repunte

Estimación a 12 Meses

Media 391.67 USD 29.65%

Máximo 465 USD

Mínimo 315 USD

De acuerdo con 23 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Stryker Corp Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

23 ratings

Comprar

Mantener

Vender

De acuerdo con 23 analistas que ofrecen calificaciones bursátiles a para Stryker Corp Dist en los últimos 3 meses.

Puntuación técnica

By Trading Central

373.92 / 383.99Soporte y Resistencia

Bullish events outweigh bearish events.

Recent bullish events outweigh bearish events.

All events are bullish.

Sentimiento

By Acuity

108 / 345 Clasificación en Sanidad

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

Acerca de Stryker Corp

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical and thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, clinical communication and workflow solutions, and other medical device products that are used in various medical specialties, as well as patient and caregiver safety technologies. This segment also provides neurosurgical, neurovascular and craniomaxillofacial implant products, which include products used for minimally invasive endovascular procedures; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.